India's metabolic health crisis — encompassing 101 million diabetics, 136 million pre-diabetics, and rapidly rising rates of hormonal and gut dysfunction — has generated two dominant but structurally incomplete intervention categories: pharmaceutical management and FMCG health food. Neither addresses daily therapeutic nutrition as a primary recovery mechanism. This paper examines how GRASA Millets and Foods Pvt Ltd identified and created an entirely new market category — food-led metabolic recovery — in India's functional food market, and what behavioural economics and category creation theory explain about that process.
Employing single case study methodology, the analysis draws on founder interviews, clinical observation data, and customer outcome records across Delhi NCR and Chandigarh. The case is analysed through two theoretical lenses: category creation theory, specifically the four structural characteristics of defensible market categories identified by Lochhead and Maney — proprietary technology, network effects, economies of scale, and branding; and behavioural economics, drawing on Kahneman and Tversky's prospect theory and Sarasvathy's effectuation framework.
Three findings emerge. First, category creation in regulated therapeutic consumer markets requires simultaneous behaviour change in two institutionally separate audiences — end consumers and medical professionals — through fundamentally different mechanisms. Second, prospect theory explains premium pricing in therapeutic food markets more accurately than conventional pricing models, and GRASA's case extends the framework to a health investment logic whose return is measured in restored functional lifespan. Third, GRASA's founding logic reveals a hybrid entrepreneurial reasoning mode — the causal identification of the market gap combined with the effectual construction of the solution — undocumented in the existing entrepreneurship literature. The findings contribute to scholarly conversations on category creation, behavioural economics of founding, and innovation systems in regulated consumer health markets.